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Summary  20 
 21 
The human gut microbiota ferments dietary non-digestible carbohydrates into short-chain fatty acids 22 
(SCFA). These microbial products are utilized by the host and propionate and butyrate in particular exert 23 
a range of health-promoting functions. Here we provide an overview of the metabolic pathways utilized 24 
by gut microbes to produce these two SCFA from dietary carbohydrates and from amino acids resulting 25 
from protein breakdown. This overview emphasizes the important role played by cross-feeding of 26 
intermediary metabolites (in particular lactate, succinate and 1,2-propanediol) between different gut 27 
bacteria. The ecophysiology, including growth requirements and responses to environmental factors, of 28 
major propionate and butyrate producing bacteria are discussed in relation to dietary modulation of 29 
these metabolites. A detailed understanding of SCFA metabolism by the gut microbiota is necessary to 30 
underpin effective strategies to optimize SCFA supply to the host. 31 
 32 
 33 
Introduction 34 
 35 
Short chain fatty acids (SCFA) are the major metabolic products of anaerobic fermentation by microbial 36 
communities that colonize the mammalian gut, typically reaching total concentrations of 50-200 mM in the 37 
human large intestine. They are taken up efficiently by the gut mucosa and have important impacts upon 38 
host physiology as sources of energy, as regulators of gene expression and as signaling molecules that are 39 
recognized by specific receptors (Morrison & Preston, 2016; Koh et al., 2016). New mechanisms by which 40 
SCFA regulate immune cell development and suppress inflammation have been uncovered recently (Louis 41 
et al., 2014; Richards et al., 2016). It is apparent however that the three major SCFA, acetate, propionate 42 
and butyrate, differ considerably in their potential effects upon host physiology. First, they differ in their 43 
fate and tissue distribution, with butyrate being used preferentially as an energy source by the gut mucosa, 44 
propionate contributing to gluconeogenesis in the liver and acetate achieving the highest systemic 45 
concentrations in blood (Morrison & Preston, 2016). Second, there are differences in interactions with host 46 
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proteins (eg. inhibition of histone deacetylases by butyrate and propionate) and receptors (Bolognini et al., 47 
2016). This makes it particularly relevant to consider the microbial origin of these major fermentation 48 
products and the potential for changes in diet and gut physiology to affect their relative production rates 49 
and concentrations. This brief review will focus on butyrate and propionate as these two acids are most 50 
often considered to benefit health, including protection against colorectal cancer in the case of butyrate 51 
and promotion of satiety and reduction in cholesterol in the case of propionate (Morrison & Preston, 2016). 52 
Acetate is a net fermentation product for most gut anaerobes that is also produced by reductive 53 
acetogenesis, and almost invariably achieves the highest concentrations among the SCFA in the gut lumen. 54 
In contrast, propionate and butyrate are produced by distinct subsets of gut bacteria. We consider here 55 
what is currently known about the phylogenetic distribution of pathways leading to the formation of these 56 
two SCFA within the human colonic microbiota and the potential for diverse dietary and environmental 57 
factors to differentially modulate their production. Some fermentation products, including lactate, 58 
succinate and 1,2-propanediol, do not usually accumulate to high levels in the human colon of healthy 59 
adults, as they can also serve as substrates for other bacteria, including propionate and butyrate producers. 60 
As the microbial metabolism of these compounds is intricately linked to the degradation of the main 61 
dietary substrates, it will be discussed together with propionate and butyrate formation from 62 
carbohydrates and proteins, respectively. 63 
 64 
 65 
Pathways and bacterial groups contributing to butyrate formation from carbohydrates 66 
 67 
Butyrate is produced from carbohydrates via glycolysis from the combination of two molecules of acetyl-68 
CoA to form acetoacetyl-CoA, followed by stepwise reduction to butyryl-CoA. Two different pathways are 69 
known for the final step in butyrate formation from butyryl-CoA, which proceeds either via butyryl-70 
CoA:acetate CoA-transferase or via phosphotransbutyrylase and butyrate kinase (Louis & Flint, 2009) (Fig. 71 
1). Butyrate-producing species are found interspersed with butyrate non-producing species in the two 72 
predominant families of human colonic Firmicutes, Ruminococcaceae and Lachnospiraceae, as well as in 73 
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other Firmicutes families, including Erysipelotrichaceae and Clostridiaceae (Barcenilla et al., 2000; Louis et 74 
al., 2004). We will briefly consider the characteristics of butyrate-producers that belong to the two most 75 
abundant families of Firmicutes. We should note that, as summarized in Table 1, many dominant human 76 
colonic Firmicutes (eg. Blautia spp., Eubacterium eligens, Ruminococcus spp.) lack the ability to form 77 
butyrate from carbohydrates.  78 
Ruminococcaceae. Faecalibacterium prausnitzii, one of the most abundant species present in the 79 
healthy human microbiota, produces butyrate via butyryl-CoA:acetate CoA-transferase with net 80 
consumption of acetate, and acetate stimulates its growth on carbohydrate energy sources (Duncan et al., 81 
2002). While F. prausnitzii strains are obligate anaerobes, they also show growth stimulation by low 82 
concentrations of oxygen in the presence of riboflavin and reduced compounds such as cysteine or 83 
glutathione (Khan et al., 2012). It is hypothesized that this ability may provide a niche for the bacterium to 84 
thrive in the proximity of the colonic wall, where oxygen is diffusing in from the bloodstream. Oxygen 85 
consumption is accompanied by a decrease in butyrate formation (Khan et al., 2012). F. prausnitzii isolates 86 
show limited ability to utilize dietary polysaccharides such as starch and hemicellulose for growth, but 87 
some strains utilize inulin and pectin derivatives and the ability to utilize uronic acids is widespread (Lopez-88 
Siles et al., 2012). F. prausnitzii is depleted in inflammatory bowel disease patients, especially Crohn’s 89 
disease, and evidence that it has anti-inflammatory action has attracted interest in this species as a 90 
potential therapeutic (Quévrain et al., 2016). Similarly Butyricicoccus pullicaecorum is also reported to be 91 
less abundant in inflammatory bowel disease patients, and might also have therapeutic potential (Eeckhaut 92 
et al., 2013). Butyrate production has been reported for other Ruminococcaceae (Table 1), but rather little 93 
is known about most of these organisms.  94 
Lachnospiraceae. Eubacterium rectale and the closely related Roseburia species constitute a major 95 
group of butyrate-producing Firmicutes that share the butyryl-CoA:acetate CoA-transferase route for 96 
butyrate production and the same genomic organization of their butyrate synthetic genes from acetyl-CoA 97 
to butyryl-CoA (Louis & Flint, 2009). In some Roseburia strains, particularly at mildly acidic pH, butyrate is 98 
almost the sole fermentation acid produced, with net consumption of acetate typically accompanying the 99 
formation of butyrate (Kettle et al., 2015). Other strains and species produce formate and lactate in 100 
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addition to butyrate (Louis & Flint, 2009). Genome analysis reveals that there is considerable capacity 101 
within this group to utilize diet-derived polysaccharides including starch, arabinoxylan and inulin, that 102 
varies substantially between strains and species (Sheridan et al., 2016). 103 
Butyrate-producing Lachnopiraceae show considerable divergence in their phylogeny, gene 104 
organization and physiology (Louis & Flint, 2009) (Table 1). Other Lachnospiraceae that possess the butyryl-105 
CoA:acetate CoA-transferase gene include Eubacterium hallii, Anaerostipes hadrus, Coprococcus catus, un-106 
characterised species related to isolates SS3/4 and M62/1, and some uncultured organisms (Louis et al., 107 
2010; Reichardt et al., 2014). Two species of Coprococcus, in common with many Clostridium species that 108 
belong to other families of Firmicutes, use the butyrate kinase rather than CoA-transferase enzyme for the 109 
final step in butyrate formation (Louis et al., 2004; Louis & Flint, 2009). E. rectale and E. hallii are among the 110 
10 most abundant species reported in the human faecal microbiota (Qin et al., 2010; Walker et al., 2011) 111 
(Table 1) and together accounted for 44% of butyryl CoA:acetate CoA-transferase sequences amplified from 112 
faecal samples of 10 healthy volunteers (Louis et al., 2010).  113 
Lactate can be produced from carbohydrates by many different gut bacteria (Duncan et al., 2004). 114 
In vitro incubations of 13C lactate with human intestinal microbiota show that the label is recovered in 115 
acetate, propionate and butyrate. The proportions of these products can vary widely, however, with acidic 116 
pH favouring butyrate (Belenguer et al., 2007). In addition, there is considerable inter-individual variation in 117 
the fate of 13C lactate, which is assumed to reflect differences in the relative abundance of lactate-utilising 118 
species within the microbiota (Bourriaud et al., 2005; Morrison et al., 2006). Certain Lachnospiraceae have 119 
the ability to grow in the presence of lactate and acetate to produce butyrate, showing an overall net 120 
stoichiometry of 4 mols of lactate and 2 mols of acetate producing 3 mols of butyrate (Duncan et al., 2004). 121 
These include the abundant species A. hadrus, which uses only D-lactate (Allen-Vercoe et al., 2012) and E. 122 
hallii, which is able to utilize both lactate isomers (Duncan et al., 2004; Muñoz-Tamayo et al., 2011). Lactate 123 
oxidation to pyruvate by direct reduction of NAD+ is energetically unfavourable. Anaerobic lactate utilisers 124 
carry a lactate dehydrogenase that operates in complex with an electron-transferring flavoprotein that 125 
couples the endergonic NAD+ reduction to ferredoxin oxidation, in a process called electron confurcation 126 
(Weghoff et al., 2014).  127 
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 129 
Pathways and bacterial groups contributing to propionate formation from carbohydrates 130 
 131 
Two pathways are known for the formation of propionate from sugar fermentation by gut bacteria. Most 132 
hexose and pentose sugars are processed through the succinate pathway (Fig.2) whereas the deoxy sugars 133 
fucose and rhamnose are metabolized by the propanediol pathway (Fig.3). 134 
The succinate pathway is found mainly in Bacteroidetes and in the Negativicutes class of Firmicutes 135 
(Reichardt et al., 2014). It is the major route for propionate formation from dietary carbohydrates driven by 136 
the abundant Bacteroidetes, and relative Bacteroidetes abundance was found to correlate with relative 137 
faecal propionate levels in human volunteers (Salonen et al., 2014). Succinate is a precursor of propionate, 138 
but can accumulate in cultures of Bacteroides spp. under growth conditions where PEP carboxykinase is 139 
repressed, eg. at high pCO2 and high dilution rates (Caspari & Macy, 1983). Conversion of succinate to 140 
propionate also requires vitamin B12 and succinate has been shown to accumulate in B12-depleted cultures 141 
of Prevotella ruminicola (Strobel 1992). Some species of Bacteroidetes, notably Prevotella copri, apparently 142 
produce succinate rather than propionate as their main fermentation product and succinate accumulation 143 
has been reported particularly in the rat gut (De Vadder et al., 2016). The succinate pathway is known to be 144 
present in some Ruminococcaceae, such as Ruminococcus flavefaciens, which also produces succinate 145 
rather than propionate as the end product (Macfarlane & Gibson, 1997). One the other hand, some human 146 
colonic bacteria belonging to the Negativicutes class of Firmicutes (eg. Phascolarctobacterium 147 
succinatutens; Watanabe et al., 2012), have the ability to convert succinate to propionate (Flint et al., 2014; 148 
Reichardt et al., 2014). This activity may explain why succinate accumulation is infrequently reported for 149 
human faecal samples, although 3 of the 14 overweight human volunteers in one recent dietary study 150 
showed elevated faecal succinate concentrations (>30 mM) in samples from a non-starch polysaccharide-151 
supplemented diet (reported in Salonen et al., 2014, Supplementary information). Other Negativicutes 152 
bacteria convert lactate to propionate either via the succinate pathway (eg. Veillonella spp.) or via the 153 
 7 
 
acrylate pathway (Megasphaera elsdenii) (Reichardt et al., 2014) (Fig. 2). The acrylate pathway has also 154 
been shown to operate recently in a species of Lachnospiraceae, Coprococcus catus (Reichardt et al., 2014). 155 
 156 
Formation of propionate and propanol from the deoxy sugars rhamnose and fucose via the 157 
propanediol pathway has been demonstrated in dominant gut commensal bacteria belonging to the 158 
Lachnospiraceae, including Roseburia inulinivorans and Blautia species (Scott et al., 2006; Reichardt et al., 159 
2014) (Table 1, Fig. 3). Metabolism of rhamnose and fucose via this pathway has also been reported for 160 
Salmonella and Listeria species (Xue et al., 2008). Other bacteria, including Bacteroides species, Escherichia 161 
coli and Anaerostipes rhamnosivorans, are able to degrade deoxy sugars via the propanediol pathway, but 162 
produce the pathway intermediate 1,2-propanediol as the final product (Saxena et al., 2010; Rodionova et 163 
al., 2013; Bui et al., 2014). 1,2-propanediol can also be produced from other sugars via the glycolysis 164 
intermediate dihydroxyacetone-phosphate and methylglyoxal by microbes including Escherichia coli, 165 
Clostridium sphenoides and the yeast Saccharomyces cerevisiae (Bennett & San, 2001; Saxena et al., 2010). 166 
Methylglyoxal is further metabolised to 1,2-propanediol either via lactaldehyde or via hydroxyacetone (Fig. 167 
3). In C. sphenoides it has been shown that 1,2-propanediol formation via dihydroxyacetone-phosphate 168 
operates under phosphate limitation and it remains to be established whether it plays a major role in the 169 
gut environment. A third pathway for 1,2-propanediol production via lactaldehyde operates from lactate in 170 
Lactobacillus buchneri. The pathway has been elucidated in a strain isolated from maize silage (Gänzle, 171 
2015), but this species has also been detected in the human gut (Mikelsaar et al., 2016).   172 
E. hallii and Lactobacillus reuteri, although unable to grow on fucose or rhamnose, are nevertheless 173 
able to utilise 1,2-propanediol to produce propionate and propanol (Gänzle, 2015; Engels et al., 2016) (Fig. 174 
3). Furthermore, metagenomic mining for dehydratases has indicated that further gut anaerobes, including 175 
Flavonifractor plautii, Intestinimonas butyriproducens and Veillonella spp. may also be able to produce 176 
propionate from this substrate (Engels et al., 2016). Thus, cross-feeding of the intermediate 1,2-177 
propanediol between different bacteria may play an important role in the production of propionate from 178 
deoxy sugars. The conversion of 1,2-propanediol to propionate, which is dependent on vitamin B12, takes 179 
place in polyhedral bodies, microcompartments that sequester the toxic pathway intermediate 180 
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propionaldehyde (Chowdhury et al., 2014). Interestingly, glycerol is converted to 1,3-propanediol and 3-181 
hydroxypropionate in L. reuteri and E. hallii by the same dehydratase that acts on 1,2-propanediol (Gänzle, 182 
2015; Engels et al., 2016) indicating that glycerol utilization may be the primary function of this enzyme in 183 
these species. It is also worth noting that the pathway intermediate 3-hydroxypropionaldehyde, also known 184 
as reuterin, is a potent antimicrobial compound (Gänzle, 2015). 185 
 186 
 187 
  188 
Butyrate and propionate formation from proteins and amino acids 189 
 190 
Propionate and butyrate are also formed as products from peptide and amino acid fermentation (Fig. 1 & 191 
2), although the numbers of amino acid-fermenting bacteria have been estimated to constitute less than 192 
1% of the large intestinal microbiota (Smith & Macfarlane, 1998; Dai et al., 2011). It is estimated that the 193 
colon receives approximately 13 g of protein and peptides per day, and large amounts of soluble protein 194 
and peptides were found in intestinal contents of sudden death victims (Smith & Macfarlane, 1998). 195 
Peptides seem to be preferred over free amino acids by gut bacteria. Low gut pH and the presence of 196 
carbohydrates reduces peptide and amino acid fermentation in vitro, which helps to explain why microbial 197 
amino acid fermentation is higher in the distal than the proximal colon contents (Smith & Macfarlane, 198 
1998). Amino acid fermentation leads to the production of potentially harmful metabolites (for example 199 
phenolic and indolic compounds, amines, ammonia) in addition to branched-chain fatty acids (BCFA) and 200 
SCFA (Smith & Macfarlane, 1997; Dai et al., 2011).  201 
In vitro incubations of faecal slurries with individual amino acids showed that propionate was 202 
produced mainly from aspartate, alanine, threonine and methionine, whereas butyrate was a major 203 
fermentation product from glutamate, lysine, histidine, cysteine, serine and methionine (Smith & 204 
Macfarlane, 1997). While several Bacteroidetes have major roles in proteolysis and in propionate formation 205 
from peptides (Macfarlane & Macfarlane, 1995), certain Firmicutes species also show high activity on 206 
amino acids, notably Intestinimonas AF211, which ferments glucose and lysine to butyrate via distinct 207 
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pathways (Bui et al., 2015) (Fig. 1). Several different pathways exist for glutamate degradation in butyrate-208 
producing bacteria, which have mainly been studied in Clostridium species not originating from gut 209 
environments (Barker, 1981; Buckel, 2001). However, there is genomic and metagenomic evidence that 210 
they are also present in some gut bacteria (Potrykus et al., 2008; Vital et al., 2014). The glutamate 211 
degradation pathways enter the main butyrate pathway either via pyruvate (3-methylasparate pathway; 212 
Clostridium limosum, Fusobacterium spp.) or crotonyl-CoA (4-aminobutyrate pathway, discussed in more 213 
detail below, and 2-hydroxyglutarate pathway, found in different Firmicutes including Acidaminococcus 214 
fermentans, Clostridium sporosphaeroides, Clostridium symbiosum, Fusobacterium spp. and 215 
Peptostreptococcus asaccharolyticus) (Fig. 1). Some bacteria belonging to the Acidaminococcaceae also 216 
degrade glutamate via the 3-methylasparate pathway, but produce propionate rather than butyrate from 217 
the intermediate pyruvate (Buckel, 2001) (Fig. 2).  218 
Glutamate degradation to 4-aminobutyrate (gamma-aminobutyrate, GABA) is carried out under 219 
acid stress to maintain intracellular pH homeostasis in a number of gut bacteria (Feehily & Karatzas, 2013), 220 
and a bacterial isolate exclusively growing on GABA has recently been found 221 
(http://www.abstractsonline.com/pp8/#!/4060/presentation/18619). As GABA also acts as a 222 
neurotransmitter, the abundance of microbes involved in the production or consumption of GABA may 223 
influence mood and behaviour. The pathway for GABA degradation is shared with succinate degradation via 224 
succinate semialdehyde and 4-hydroxybutyrate (Fig. 1), and butyrate production from succinate via this 225 
pathway has been demonstrated in Porphyromonas gingivalis and Clostridioides difficile (Ferreyra et al., 226 
2014; Yoshida et al., 2016). 227 
The fermentation routes of other amino acids are less well understood. Histidine is converted to 228 
glutamate (Potrykus et al., 2008; Kanehisa et al., 2016), which is in agreement with high levels of butyrate 229 
being formed from histidine by faecal microbiota (Smith & Macfarlane, 1997). Alanine, serine and cysteine 230 
are broken down to pyruvate (Potrykus et al., 2008; Carbonero et al., 2012), thus product formation 231 
depends on the bacterium utilizing those amino acids and their corresponding fermentative pathways. For 232 
example, in Clostridium propionicum, alanine fermentation leads to the production of propionate via 233 
pyruvate, lactate and the acrylate pathway (Buckel, 2001) (Fig. 2). Threonine and methionine are converted 234 
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to 2-oxobutyrate, which leads to propionate formation (Fig. 2) (Barker, 1981; Smith & Macfarlane, 1997; 235 
Kanehisa et al., 2016). Several routes for the breakdown of asparate exist, via alanine, threonine, 236 
oxaloacetate or fumarate (Smith & Macfarlane, 1997; Kanehisa et al., 2016) (Fig. 2), which accounts for the 237 
fact that it is mainly converted to propionate in in vitro incubations. 238 
 239 
 240 
Role of CoA-transferases in SCFA metabolism 241 
 242 
Propionate and butyrate can be generated from their respective CoA thioesters either by transfer of the 243 
CoA-moiety onto another metabolite, or by conversion via propionyl-phosphate or butyryl-phosphate. The 244 
second (kinase) route leads to the generation of ATP, but the CoA-transferase route also conserves the 245 
energy of the CoA bond in the newly formed CoA-derivative of the co-substrate. Acetate is a common co-246 
substrate in CoA-transferase reactions, and the high acetate concentrations in the large intestine provide a 247 
possible explanation for the prevalence of the butyryl-CoA:acetate CoA-transferase route in gut microbes 248 
(Louis et al., 2004) (see also section on pH below). Bacteria often carry multipble different CoA-transferases 249 
in their genomes, with Intestinimonas AF211 encoding at least 14 such enzymes (Bui et al., 2015). It can be 250 
difficult to pin-point which gene is responsible for SCFA formation, especially as CoA-transferases tend to 251 
have broad substrate specificity. For example, the purified butyryl-CoA:acetate CoA-transferase (butCoAT 252 
gene product) from Roseburia hominis has a similar affinity for butyryl-CoA and propionyl-CoA although the 253 
enzyme is clearly responsible for butyrate formation in this species (Charrier et al., 2006) (Table 2). Gene 254 
expression evidence in Intestinimonas AF211 suggested that the enzyme AtoD-A, responsible for butyryl 255 
CoA:acetoacetate CoA-transferase activity, plays a key role in conversion of lysine to butyrate, while the 256 
ButCoA gene product mediated the final step in butyrate formation from glucose (Bui et al., 2015). In 257 
Clostridium aminobutyricum, a CoA-transferase that acts on 4-hydroxybutyrate and butyryl-CoA links the 258 
final step of butyrate production to the formation of 4-hydroxybutyryl-CoA further up in the glutamate 259 
fermentation pathway (Buckel, 2001). Similarly, C. propionicum links the formation of lactoyl-CoA in the 260 
acrylate pathway to propionate formation via a CoA-transferase (Buckel, 2001).  There are also instances 261 
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where different CoA-transferases appear to have evolved for the same enzymatic reaction. Thus, bacteria 262 
belonging to the Erysipelotrichaceae do not carry a gene closely related to the butyryl-CoA:acetate CoA-263 
transferase identified in other Firmicutes.  Instead, a gene more closely related to propionate CoA-264 
transferases is thought to be responsible for butyrate formation in these organisms (Eeckhaut et al., 2011). 265 
 266 
 267 
Impact of the gut environment 268 
 269 
pH. Gut pH has a major impact on competition between different groups of bacteria within the microbial 270 
community. In pH-controlled in vitro continuous culture experiments with soluble polysaccharide provided 271 
as the main energy source, mildly acidic pH has been shown to curtail the growth of Bacteroides spp. 272 
relative to Firmicutes and Actinobacteria (Walker et al., 2005; Chung et al., 2016). This is because human 273 
colonic Bacteroides spp. are generally less able than many dominant Firmicutes to tolerate the presence of 274 
short chain fatty acids at pH 5.5 (Duncan et al., 2009). This selective inhibition and the resulting shift in 275 
community composition has the consequence of limiting propionate formation and enhancing butyrate 276 
production by the community at pH values around 5.5 compared with 6.5-6.8 (Walker et al., 2005; Chung et 277 
al., 2016).  The impact of pH shifts upon experimentally observed butyrate and propionate concentrations 278 
has been successfully modelled mathematically, based on the differing tolerance to low pH of the major 279 
bacterial functional groups that comprise the human colonic microbiota (Kettle et al., 2015). 280 
 For bacteria that use the butyryl-CoA:acetate CoA-transferase route, acetate consumption and 281 
butyrate production are reported to increase at mildly acidic pH compared with near neutral pH (Kettle et 282 
al., 2015). Although conversion of glucose to butyrate, 2 CO2 and 2 H2 can occur with no net uptake of 283 
acetate (Gottschalk, 1979), net acetate uptake is typically observed for species of Roseburia and F. 284 
prausnitzii. Theoretical stoichiometries involving net acetate uptake are shown in Fig. 4A, which also 285 
assumes that some of the reducing power that is generated drives proton export, increasing the ATP yield 286 
per glucose fermented (Buckel & Thauer, 2013). Incorporation of exogenous acetate via the CoA-287 
transferase reaction results in some loss of ATP production via acetyl-phosphate, but this is more than 288 
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compensated by the additional ATP formed from proton export, giving a potential maximum of 4 ATP 289 
formed per glucose metabolized when 2 mols of acetate are taken in for each mol of glucose fermented. 290 
Interestingly, Fig. 4B shows that the predictions from these stoichiometries (based on the generalised 291 
equation shown in Fig. 4A) fit experimental data for the impact of pH on metabolites produced by F. 292 
prausnitzii and two Roseburia spp. in anaerobic batch culture (Kettle et al., 2015). Thus low pH (5.5) tends 293 
to increase acetate uptake and butyrate production while near neutral pH (6.7) has the opposite effect. It 294 
seems possible that the increased ATP gain associated with net acetate uptake helps to compensate for the 295 
effects of low pH and might account for the reliance in the CoA-transferase route for butyrate formation in 296 
these bacteria. 297 
Growth requirements. It has been show in a rodent model that limitation of dietary iron intake can 298 
dramatically decrease the production of both butyrate and propionate as lactobacilli and Proteobacteria 299 
are favoured (Dostal et al., 2012). Populations of Roseburia-related butyrate producers appear particularly 300 
sensitive to iron availability, while in pure cultures of R. intestinalis butyrate production was favoured at 301 
high iron concentrations with a switch to lactate production under iron-deficient conditions (Dostal et al., 302 
2015). It remains to be established whether other growth factors also have a major impact on SCFA 303 
formation. 304 
Intestinal gases. SCFA formation is also likely to be affected by differences in oxygen concentration 305 
in different regions and micro-compartments of the gut due to differences in oxygen sensitivity and 306 
metabolic capacity between microbes, as exemplified by the peculiar relationship of F. prausnitzii with 307 
oxygen (discussed above). Furthermore, the abundance of microbes consuming hydrogen and thereby 308 
influencing the hydrogen partial pressure in the gut also influences SCFA formation, as this affects the 309 
overall balance of fermentation products formed (Macfarlane & Macfarlane, 2003; Wolf et al., 2016).  310 
 311 
 312 
Concluding remarks 313 
 314 
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Huge advances have been made in recent years in our understanding of SCFA metabolism in the human 315 
gut, and many of the dominant propionate- and butyrate-producing bacteria are available in culture, 316 
enabling detailed investigations into their metabolism. Recent work has emphasized that butyrate and 317 
propionate can arise from fermentation both of amino acids and of carbohydrates, but the relative 318 
contributions of protein and carbohydrate fermentation in vivo over the wide range of ‘normal’ human 319 
dietary intakes is not yet clear.  We know that high protein, low carbohydrate weight loss diets lead to a 320 
disproportionate decrease in butyrate among total faecal SCFA, together with an increased proportion of 321 
branched chain fatty acids that are wholly derived from branched chain amino acids and therefore provide 322 
an indicator of protein fermentation (Duncan et al., 2007, Russell et al., 2011). This suggests strongly that 323 
butyrate production is mainly determined by the supply of non-digestible carbohydrates, rather than by 324 
protein fermentation. This may however reflect the particular ecology of butyrate-producing bacteria, as 325 
discussed above. In the case of propionate, on the other hand, the major producers of propionate from 326 
dietary carbohydrates, the Bacteroidetes, are also important peptide fermenters and the propionate 327 
proportion among faecal SCFA was not decreased by such low carbohydrate diets (Duncan et al., 2007). It is 328 
also clear that compounds normally regarded as intermediates (eg. succinate, lactate) may accumulate in 329 
certain individuals or in particular conditions. This makes it important also to consider the impacts of these 330 
metabolites on the host, as for example in the case of succinate which it is suggested may provide health 331 
benefits (De Vadder et al., 2016). Lactate is detected as a major fermentation product in breast-fed infants 332 
whose microbiota is dominated by Bifidobacterium spp. In adults, however, lactate accumulation is 333 
associated with dysbiosis, eg, in severe colitis (Hove et al., 1994), that may result in part from a lack of 334 
lactate-utilizing bacteria (Belenguer et al., 2007). 335 
The ever-increasing availability of genomic and metagenomics sequences is a highly useful resource 336 
to foster our understanding of microbial metabolism in the gut, but care has to be taken with assigning 337 
function to genes by sequence analysis, which should ideally be complemented by evidence from genetic or 338 
enzymatic studies. A renewed interest in isolation and study of gut bacteria (Walker et al., 2014, Browne et 339 
al., 2016) together with novel systems for gene transfer and knockout on the horizon will enable a 340 
thorough understanding of the different members of the microbial community. This will benefit in vitro and 341 
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in vivo microbial community-based studies to foster our understanding of the different ecological niches of 342 
the community members, how they interact with each other and how we can modulate the system by 343 
dietary means to optimize SCFA production. The fact that, in general, different phylogenetic groups of 344 
bacteria are responsible for butyrate and propionate production suggests that there may be scope for 345 
differentially manipulating their production by the gut microbiota. 346 
 347 
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Figure legends 546 
 547 
Fig. 1. Microbial pathways for butyrate formation from carbohydrates, organic acids, glutamate and lysine 548 
in gut communities. Carbohydrate fermentation to pyruvate via glycolysis is shown in green, butyrate 549 
formation from acetyl-CoA in black, amino acid fermentation pathways in blue (intermediates after which 550 
the different glutamate pathways are named are highlighted), and lactate and succinate fermentation in 551 
purple and pink, respectively. See main text for key enzymes and bacteria harbouring the different 552 
pathways. Redox reactions which involve electron carriers are indicated by [H]. CoA-transferase-mediated 553 
reactions are indicated by ●. As indicated, co-substrates other than acetate may operate in CoA-transferase 554 
reactions in some bacteria (for further detail see main text). CoA, coenzyme A; P, bound phosphate; Pi, 555 
inorganic phosphate; PEP, phosphoenolpyruvate; (B12), enzyme dependent on vitamin B12. Dotted line 556 
indicates that several intermediate steps are involved. 557 
 558 
Fig. 2. Microbial pathways for propionate formation from carbohydrates, organic acids and amino acids. As 559 
indicated, amino acids capable of conversion to pyruvate can also give rise to butyrate (Fig. 1). 560 
Carbohydrate fermentation to pyruvate via glycolysis is shown in green, propionate formation via the 561 
succinate pathway in black, amino acid fermentation pathways in blue, and acrylate pathway for lactate 562 
utilisation in purple. See main text for key enzymes and bacteria harbouring the different pathways. Redox 563 
reactions which involve electron carriers are indicated by [H]. CoA-transferase-mediated reactions are 564 
indicated by ● (*may be performed by a CoA-transferase or CoA-ligase reaction). Propionate formation 565 
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from propionyl-CoA in the succinate pathway may involve either a CoA-transferase or phosphate 566 
propanoyltransferase/propionate kinase reaction. CoA, coenzyme A; PEP, phosphoenolpyruvate; (B12), 567 
dependent on vitamin B12,. Dotted lines indicate that several intermediate steps are involved. 568 
 569 
Fig. 3. Microbial pathways for propionate formation via 1,2-propanediol. Carriage of the different pathways 570 
in gut microbes is indicated by colour. Redox reactions which involve electron carriers are indicated by [H]. 571 
Propionate formation from propionyl-CoA may involve either a CoA-transferase or phosphate 572 
propanoyltransferase/propionate kinase reaction (indicated by a dashed line). Grey hexagon indicates that 573 
the reaction is carried out in polyhedral bodies to sequester toxic intermediate propionaldehyde. CoA, 574 
coenzyme A; P, bound phosphate; (B12), dependent on vitamin B12. Dotted line indicates that several 575 
intermediate steps are involved. 576 
 577 
Fig. 4. Butyrate production in bacteria that use the butyryl-CoA:acetate CoA-transferase route. A: General 578 
equation for the relationship between acetate consumption and butyrate production, assuming no lactate 579 
or formate are produced (modified from Louis & Flint 2009 and Kettle et al. 2015). Etf, electron-transferring 580 
flavoprotein; Fd, ferredoxin; P, bound phosphate; Pi, inorganic phosphate. B: Alternative stoichiometries 581 
for butyrate production based on A. Experimental data (coloured symbols) refer to R. intestinalis L1-82, R. 582 
hominis A2-183 and F. prausnitzii A2-165 grown at three different initial pH values (5.5, 6.2, 6.7) (Kettle et 583 
al 2015 and Sylvia Duncan, personal communication). 584 
 585 
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Table 1. Capabilities for butyrate and propionate production among dominant bacterial species detected in 586 
faecal samples of human subjects (Qin et al., 2010; Zhernakova et al., 2016) 587 
Phylum (family) species Butyrate1 Propionate2 
Bacteroidetes (Bacteroidaceae) Bacteroides uniformis - + (Suc) 
 Bacteroides vulgatus - + (Suc) 
Bacteroidetes (Prevotellaceae) Prevotella copri - + (Suc) 
Bacteroidetes (Rikenellaceae) Alistipes putredinis - + (Suc) 
Firmicutes (Lachnospiraceae) Eubacterium rectale + (CoAT) - 
 Roseburia inulinivorans + (CoAT) + (Pdu) 
 Roseburia intestinalis + (CoAT) - 
 Dorea longicatena -  - 
 Eubacterium hallii + (CoAT) + (Pdu) 
 Anaerostipes hadrus + (CoAT) - 
 Ruminococcus torques - - 
 Coprococcus eutactus + (ButK) - 
 Blautia obeum - + (Pdu) 
 Dorea formicigenerans - - 
 Coprococcus catus + (CoAT) + (Acr) 
Firmicutes (Ruminococcaceae) Faecalibacterium prausnitzii + (CoAT) - 
 Subdoligranulum variabile + (ButK) - 
 Ruminococcus bromii - - 
 Eubacterium siraeum - - 
Firmicutes (Veillonellaceae) Dialister invisus - + (Suc) 
Firmicutes (Acidaminococcaceae) Phascolarctobacterium succinatutens - + (Suc) 
Firmicutes (Erysipelotrichaceae) Eubacterium biforme3 + (CoAT) - 
Actinobacteria (Bifidobacteriaceae) Bifidobacterium adolescentis - - 
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 Bifidobacterium longum - - 
Actinobacteria (Coriobacteriaceae) Collinsella aerofaciens - - 
Verrucomicrobia 
(Verrucomicrobiaceae) 
Akkermansia muciniphila - + (Suc) 
 588 
1-, absent; +, present; ButK, butyrate kinase route; CoAT, butyryl-CoA:acetate CoA-transferase route. 589 
2-, absent; +, present; Acr, acrylate pathway; Pdu, 1,2-propanediol pathway; Suc, succinate pathway 590 
(succinate may be the major product formed instead of propionate in some species and/or under some 591 
growth conditions). 592 
3Reclassified as Holdemanella biformis (De Maesschalck et al., 2014). CoA-transferase route is proposed 593 
based on closely related butyrate producers within the Erysipelotrichaceae (see also main text, section on 594 
CoA-transferases). 595 
 596 
  597 
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Table 2. Activity of the butyryl-CoA:acetate CoA-transferase of Roseburia hominis A2-183 (purified 598 
recombinant butCoAT gene product expressed in Escherichia coli (Charrier et al., 2006)). 599 
 600 
 
Km [mM] Vmax [µmol/min/mg 
protein] 
Inhibition by 
competition with 
acetate [%]1 
acetate 6.4   
butyryl CoA 0.098 112  
propionyl CoA 0.099 51  
Butyrate   75 
Propionate   70 
Isobutyrate   56 
Valerate   28 
1No significant inhibition was found for caproate, 3-hydroxybutyrate, 4-hydroxybutyrate, 4-aminobutyrate, 601 
lactate, acetoacetate and succinate. 602 
  603 
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  604 
PEP
lactate
pyruvate
carbohydrates
acetyl-CoA
acetyl-CoA
acetoacetyl-CoA
3-hydroxybutyryl-CoA
crotonyl-CoA
butyryl-CoA
butyrate
butyryl-P
acetyl-CoA
or acetoacetyl-CoA 
or 4-hydroxybutyryl-CoA
acetate
or acetoacetate 
or 4-hydroxybutyrate
L-3-aminobutyryl-CoA
5-amino-3-oxohexanoate
3,5-diaminohexanoate
3,6-diaminohexanoate
L-lysine
acetyl-CoA
acetoacetate
2[H]
glutaconyl-CoA
2-hydroxyglutaryl-CoA
2-hydroxyglutarate
2-oxoglutarate
4-hydroxybutyryl-CoA
4-hydroxybutyrate
succinate semialdehyde
H2O
2[H]
2[H]
H2O
CoA
CoA
formate or
CO2 + 2 [H]
2[H]
acetyl-CoA
acetate
H2O
CO2
2-oxoglutarate 
or pyruvate or glyoxylate
L-glutamate 
or L-alanine or glycine
4-aminobutyrate
2[H]
acetyl-CoA
or butyryl-CoA 
acetate
or butyrate 
H2O
ADP
ATP
L- glutamate
CO2
succinyl-CoA
L- glutamate
3-methylasparate
mesaconate
citramalate
L- glutamate
2[H]NH4
+
CoA
Pi
ADP
ATP
2[H]
(B12)
H2O
acetate
succinate
acetyl-CoA
acetate
H2O
NH4
+
NH4
+
NH4
+
2[H]
2[H]
CoA
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succinate
PEP
CO2
pyruvate oxaloacetate
propionate
alanine
2-oxoglutarate
glutamate
propionate
carbohydrates
butyrate
glutamate
lysine
histidine
serine
malate
fumarate
succinyl-CoA
R-methylmalonyl-CoA
S-methylmalonyl-CoA
propionyl-CoA
lactate
lactoyl-CoA
acryloyl-CoA
propionyl-CoA
2[H]
H2O
propionyl-CoA
propionate
lactate
lactoyl-CoA
2[H]
2[H]
H2O
CoA*
2-oxobutyrate
threonine
NH4
+
methionine
CoA
formate
aspartate
(see Fig. 1)
2-oxoglutarate
glutamate
NH4
+
NH4
+
cysteine
H2O
H2S + NH4
+
H2O
CH3SH 
+ NH4
+
CO2
2[H]
ADP
ATP
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fucose or 
rhamnose
lactaldehyde
Roseburia inulinivorans
Blautia obeum
Salmonella enterica
Listeria spp.
1,2-propanediol
propionaldehyde propanol
dihydroxyacetone-P
fuculose-1-P or 
rhamnulose-1-P
fuculose or 
rhamnulose
methylglyoxalphosphate
hydroxy-
acetone
most 
monosaccharides
fructose-1,6-bis-P
glyceraldehyde-3-P
lactate
Lactobacillus buchneri
Clostridium sphenoides
Escherichia coli
Saccharomyces cerevisiae
Eubacterium hallii
Lactobacillus reuteri
Bacteroides thetaiotaomicron
Anaerostipes rhamnosivorans
Escherichia coli
propionyl-CoA
2[H]
2[H]
2[H]
2[H]2[H]
2[H]
2[H] H2O
propionate
(B12)
Fig. 3
CoA
ADP
ATP
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Fig. 4
glucose
2 pyruvate
y acetoacetyl-CoA
y acetyl-CoA
y 3-hydroxybutyryl-CoA
y butyryl-CoA
y crotonyl-CoA
n acetate
y butyrate
2 NAD+
y NADH
y NAD+
y Fdox
y EtfH2
y Etf2y NADH
2y NAD+
(2 - n) Fdox (2 + y) Fdred
2- (y + n) NAD+ (y + n) NADH     (y + n) Fdox
2 (y + n) H+ (or Na+)
(2 - y) acetyl-P                    2 acetyl-CoA
(2 – y) ADP
(2 – y) ATP
2 ADP
2 ATP
2 CoA
2 CO2
(2 – n) H2
y CoA
(2 – y) CoA   (2 – y) Pi
y acetate
2 NADH
2 Fdox
y H2O
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butyrate
R. intestinalis butyrate
R. hominis butyrate
F. prausnitzii butyrate
H2
ATP
butyrate
R. intestinalis butyrate
R. hominis butyrate
F. prausnitzii butyrate
H2
ATP
General equation:
glucose + n acetate 
(1 + n/2) butyrate + 2 CO2 + (2 - n) H2
[In the diagram y = (1 + n/2)]
ATP/ glucose: 2 + (2 – y) + (2 (y + n))/4 ATP 
[asssuming generation of  1 ATP per 4 H+]
